Sort by

Send to

Choose Destination

Links from PubMed

Items: 10


Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.

Hernández JE, Llacuachaqui M, Palacio GV, Figueroa JD, Madrid J, Lema M, Royer R, Li S, Larson G, Weitzel JN, Narod SA.

Hered Cancer Clin Pract. 2014 Apr 17;12(1):11. doi: 10.1186/1897-4287-12-11. eCollection 2014.


BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families.

Elnour AM, Elderdery AY, Mills J, Mohammed BA, Elbietabdelaal D, Mohamed AO, Elhassan KE, A AH, Wahab A, Cooper A.

Int J Health Sci (Qassim). 2012 Jan;6(1):63-71.


Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

Dutil J, Colon-Colon JL, Matta JL, Sutphen R, Echenique M.

Cancer Genet. 2012 May;205(5):242-8. doi: 10.1016/j.cancergen.2012.04.002.


The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.

Stegel V, Krajc M, Zgajnar J, Teugels E, De Grève J, Hočevar M, Novaković S.

BMC Med Genet. 2011 Jan 14;12:9. doi: 10.1186/1471-2350-12-9.


The pathology of hereditary breast cancer.

Honrado E, Benítez J, Palacios J.

Hered Cancer Clin Pract. 2004 Jul 15;2(3):131-8. doi: 10.1186/1897-4287-2-3-131.


Performance of BRCA1/2 mutation prediction models in Asian Americans.

Kurian AW, Gong GD, Chun NM, Mills MA, Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, Ridge Y, Panabaker K, West DW, Whittemore AS, Ford JM.

J Clin Oncol. 2008 Oct 10;26(29):4752-8. doi: 10.1200/JCO.2008.16.8310. Epub 2008 Sep 8.


Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.

Litwiniuk MM, Roznowski K, Filas V, Godlewski DD, Stawicka M, Kaleta R, Breborowicz J.

BMC Cancer. 2008 Apr 13;8:100. doi: 10.1186/1471-2407-8-100.


Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.

Miolo G, Puppa LD, Santarosa M, De Giacomi C, Veronesi A, Bidoli E, Tibiletti MG, Viel A, Dolcetti R.

BMC Cancer. 2006 Jun 9;6:156.


BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families.

Claes K, Poppe B, Coene I, Paepe AD, Messiaen L.

Br J Cancer. 2004 Mar 22;90(6):1244-51.


Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics.

de la Hoya M, Díez O, Pérez-Segura P, Godino J, Fernández JM, Sanz J, Alonso C, Baiget M, Díaz-Rubio E, Caldés T.

J Med Genet. 2003 Jul;40(7):503-10.

Items per page

Supplemental Content

Write to the Help Desk